172 related articles for article (PubMed ID: 30431136)
1. Epigenetic knockdown of Notch1 inhibits hepatitis B virus X protein‑induced hepatocarcinogenesis of L02/HBx cells.
Peng Y; Zhou D; Ye Y; Kai C; Jiang Z; Zhu Z; Wu X; Xiong J
Oncol Rep; 2019 Feb; 41(2):1151-1159. PubMed ID: 30431136
[TBL] [Abstract][Full Text] [Related]
2. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma.
Sun Q; Wang R; Wang Y; Luo J; Wang P; Cheng B
Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972
[TBL] [Abstract][Full Text] [Related]
3. Notch1 promotes hepatitis B virus X protein-induced hepatocarcinogenesis via Wnt/β-catenin pathway.
Sun Q; Wang R; Luo J; Wang P; Xiong S; Liu M; Cheng B
Int J Oncol; 2014 Oct; 45(4):1638-48. PubMed ID: 25017705
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137.
Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X
Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447
[TBL] [Abstract][Full Text] [Related]
5. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage.
Xu J; Yun X; Jiang J; Wei Y; Wu Y; Zhang W; Liu Y; Wang W; Wen Y; Gu J
Hepatology; 2010 Jul; 52(1):142-54. PubMed ID: 20578140
[TBL] [Abstract][Full Text] [Related]
7. Notch1 signaling contributes to the oncogenic effect of HBx on human hepatic cells.
Wang F; Xia X; Wang J; Sun Q; Luo J; Cheng B
Biotechnol Lett; 2013 Jan; 35(1):29-37. PubMed ID: 22986536
[TBL] [Abstract][Full Text] [Related]
8. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells.
Luo J; Zhou H; Wang F; Xia X; Sun Q; Wang R; Cheng B
Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368
[TBL] [Abstract][Full Text] [Related]
9. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells.
Kong F; Hu W; Zhou K; Wei X; Kou Y; You H; Zheng K; Tang R
J Exp Clin Cancer Res; 2016 Nov; 35(1):172. PubMed ID: 27821177
[TBL] [Abstract][Full Text] [Related]
11. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
[TBL] [Abstract][Full Text] [Related]
12. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma.
Liao B; Zhou H; Liang H; Li C
Int J Oncol; 2017 Nov; 51(5):1449-1459. PubMed ID: 29048612
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.
Gao J; Xiong Y; Wang Y; Wang Y; Zheng G; Xu H
Int J Oncol; 2016 Jan; 48(1):329-37. PubMed ID: 26530164
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
[TBL] [Abstract][Full Text] [Related]
15. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
[TBL] [Abstract][Full Text] [Related]
16. HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.
Qiu X; Dong S; Qiao F; Lu S; Song Y; Lao Y; Li Y; Zeng T; Hu J; Zhang L; Zhang L; Fan H
Oncogene; 2013 Jul; 32(27):3296-305. PubMed ID: 23604124
[TBL] [Abstract][Full Text] [Related]
17. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
[TBL] [Abstract][Full Text] [Related]
18. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
Zhang Y; Yan Q; Gong L; Xu H; Liu B; Fang X; Yu D; Li L; Wei T; Wang Y; Wong CN; Lyu Z; Tang Y; Sham PC; Guan XY
Oncogene; 2021 Feb; 40(6):1147-1161. PubMed ID: 33323975
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of microRNA and mRNA expression profiles in HBx-expressing hepatic cells.
Chen RC; Wang J; Kuang XY; Peng F; Fu YM; Huang Y; Li N; Fan XG
World J Gastroenterol; 2017 Mar; 23(10):1787-1795. PubMed ID: 28348484
[TBL] [Abstract][Full Text] [Related]
20. HBx represses RIZ1 expression by DNA methyltransferase 1 involvement in decreased miR-152 in hepatocellular carcinoma.
Zhao Z; Hu Y; Shen X; Lao Y; Zhang L; Qiu X; Hu J; Gong P; Cui H; Lu S; Zheng Y; Zhou M; Fan H
Oncol Rep; 2017 May; 37(5):2811-2818. PubMed ID: 28339081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
